EUVIMEDEUVIMED entdecken
Crossref

Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: indications diversity and future perspectives

A. Tzikas, T. Lewalter

Continuing Cardiology Education · 2016

DOI: 10.1002/cce2.18 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Continuing Cardiology Education, 2016. Verfasst von A. Tzikas und 1 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Left atrial appendage occlusion (LAAO) is a promising alternative to oral anti‐coagulation in patients with non‐valvular atrial fibrillation. Recently, four‐year results of PROTECT‐AF demonstrated superiority of LAAO in all‐cause mortality and stroke reduction compared to optimal medical treatment with warfarin. In this new era, it is important to identify the patients who would benefit more from LAAO and offer them priority for treatment. Answer questions and earn CME: https://wileyhealthlearning.com/Activity2/4193475/Activity.aspx

Zitieren

APA

Tzikas, A., & Lewalter, T. (2016). Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: indications diversity and future perspectives. Continuing Cardiology Education. https://doi.org/10.1002/cce2.18

Vancouver

Tzikas A, Lewalter T. Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: indications diversity and future perspectives. Continuing Cardiology Education. 2016. doi:10.1002/cce2.18

BibTeX
@article{Tzikas2016,
  author = {Tzikas, A. and Lewalter, T.},
  title = {Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: indications diversity and future perspectives},
  journal = {Continuing Cardiology Education},
  year = {2016},
  doi = {10.1002/cce2.18}
}
Kostenlos starten →